Even though the pandemic has caused a crisis in many countries around the world and most of them have already started to implement a national vaccination plan, the reality is that there are still several nations that still cannot afford it, needing even more help to get rid of the devastation caused by the disease.
Fortunately, the World Health Organization is aware of this and, together with the German company Pfizer, has agreed to team up for the distribution of 40 million doses to be directed to underdeveloped countries.
This agreement would also include the entry of the German pharmaceutical company into the Covax platform (COVID-19 Vaccines Global Access), which is an alliance led by both public and private actors, with the aim of guaranteeing equitable access to vaccines against COVID-19. Formulas created by Moderna and AstraZeneca are already on this platform.
The director general of the WHO, Tedros Adhanom Ghebreyesus, added that it will be around February when the so-called "Global Access Fund for COVID-19 Vaccines" (Covax) will start distributing the doses.
A few days ago Anthony Fauci, head of infectious diseases in the United States, announced the entry of the American country to this platform, since during Donald Trump's term, the former president had announced that he would not be part of this initiative, which has as its main goal to apply around 2 billion vaccines to one fifth of the world's population, according to the words of Pfizer's president, Alberta Bourla.
Negotiations are currently underway with the United Nations Children's Fund (UNICEF) and the Pan American Health Organization (PAHO) to begin with the logistics and shipment of the vaccines. The 190 countries that are part of Covax will be informed of the date on which they will begin in approximately one week's time.